Am. J. Respir. Crit. Care Med., Volume 161, Number 5, May 2000, 1713-1719

Diagnosis of Tuberculosis by a Visually Detectable Immunoassay for Lipoarabinomannan

EDWARD D. CHAN, RANDALL REVES, JOHN T. BELISLE, PATRICK J. BRENNAN, and WILLIAM E. HAHN

Division of Pulmonary Sciences and Critical Care Medicine, and Department of Cellular and Structural Biology, University of Colorado Health Sciences Center, and National Jewish Medical and Research Center, Denver, Colorado; Denver Metro Tuberculosis Clinic, Denver Health Medical Center, Denver, Colorado; and Department of Microbiology, Colorado State University, Fort Collins, Colorado

Recovery of tubercle bacilli from sputum, tissue, or body fluid is the standard for the diagnosis of tuberculosis (TB) although this process is technically demanding and relatively insensitive. We have developed a simplified, visually detectable, colloidal gold-based serological assay to qualitatively detect IgG directed against the mycobacterial cell wall component lipoarabinomannan (LAM). The objective of this investigation is to determine the accuracy of this assay in patients with active pulmonary TB and in control patients with or without latent infection. In patients with active TB, the sensitivity of anti-LAM IgG was 85 to 93%. In five patients with active TB who were smear-negative, all tested positive for anti-LAM IgG. The specificity of the test depended on the presence of tuberculous infection. In U.S. citizens comprised of young healthy adults and rheumatology patients, the specificity was 100%. In an at-risk population for tuberculous infection who were either tuberculin skin test-negative or positive, the specificity was 89%. The negative and positive predictive values of the test were 98% and 52%, respectively. We conclude that anti-LAM IgG immunoassay is relatively sensitive and specific for active TB and thus, a potentially useful screening test for active TB.

This article has been cited by other articles:

				G. Senol, O. F. Erer, Y. A. Yalcin, M. Coskun, A. T. Gunduz, C. Bicmen, M. Ertas, and S. A. Ozkan Humoral immune response against 38-kDa and 16-kDa mycobacterial antigens in tuberculosis Eur. Respir. J., January 1, 2007; 29(1): 143 - 148. [Abstract] [Full Text] [PDF]

				Y. Okuda, R. Maekura, A. Hirotani, S. Kitada, K. Yoshimura, T. Hiraga, Y. Yamamoto, M. Itou, T. Ogura, and T. Ogihara Rapid Serodiagnosis of Active Pulmonary Mycobacterium tuberculosis by Analysis of Results from Multiple Antigen-Specific Tests J. Clin. Microbiol., March 1, 2004; 42(3): 1136 - 1141. [Abstract] [Full Text] [PDF]

				E. Julian, L. Matas, J. Alcaide, and M. Luquin Comparison of Antibody Responses to a Potential Combination of Specific Glycolipids and Proteins for Test Sensitivity Improvement in Tuberculosis Serodiagnosis Clin. Vaccine Immunol., January 1, 2004; 11(1): 70 - 76. [Abstract] [Full Text] [PDF]

				M. Kameswaran, K. Shetty, M. K. Ray, M. A. Jaleel, and G. V. Kadival Evaluation of an In-House-Developed Radioassay Kit for Antibody Detection in Cases of Pulmonary Tuberculosis and Tuberculous Meningitis Clin. Vaccine Immunol., September 1, 2002; 9(5): 987 - 993. [Abstract] [Full Text] [PDF]

				M. J. TOBIN Tuberculosis, Lung Infections, and Interstitial Lung Disease in AJRCCM 2000 Am. J. Respir. Crit. Care Med., November 15, 2001; 164(10): 1774 - 1788. [Full Text] [PDF]

				M. J. Tobin Taxonomy of AJRCCM, a New Series, and a Medley of Metaphors Am. J. Respir. Crit. Care Med., October 15, 2001; 164(8): 1333 - 1335. [Full Text] [PDF]